The efficacy and safety of secukinumab in psoriasis patients has been demonstrated in randomized controlled clinical trials.
No takes yet. Share an insight, caveat, or question.
Acer et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: